| DIRECT COMPETITOR COMPARISON | |
| SVNT | PRX | Pvt1 | Pvt2 | Industry | | Market Cap: | 896.11M | 829.04M | N/A | N/A | 104.07M | | Employees: | 73 | 654 | 1,0001 | 1501 | 68 | | Qtrly Rev Growth (yoy): | -39.50% | 97.90% | N/A | N/A | 19.70% | | Revenue (ttm): | 3.19M | 1.06B | 300.00M1 | 200.00K1 | 14.01M | | Gross Margin (ttm): | 51.91% | 28.00% | N/A | N/A | 65.67% | | EBITDA (ttm): | -85.74M | 140.74M | N/A | N/A | -12.30M | | Oper Margins (ttm): | -2,699.28% | 9.73% | N/A | N/A | -149.46% | | Net Income (ttm): | -114.98M | 39.79M | N/A | N/A | N/A | | EPS (ttm): | -2.012 | 1.117 | N/A | N/A | -0.33 | | P/E (ttm): | N/A | 21.32 | N/A | N/A | 16.37 | | PEG (5 yr expected): | N/A | 0.19 | N/A | N/A | 1.31 | | P/S (ttm): | 277.23 | 0.78 | N/A | N/A | 9.43 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.39 | -0.19% | 57.07B | 12.30 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.10 | 0.38% | 13.62B | 15.76 | | Genzyme Corp. | GENZ | 50.78 | -0.57% | 13.48B | 28.95 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.25 | -0.67% | 41.62B | 17.88 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.78 | -0.34% | 8.88B | 1015.92 | | Teva Pharmaceutical Industries Limited | TEVA | 52.76 | -0.23% | 46.48B | 48.27 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.14 | 0.49% | 3.94B | 19.14 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.835 | -0.96% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.91 | -0.56% | 5.47B | 109.88 | | Pfizer Inc. | PFE | 18.2575 | 0.04% | 147.33B | 15.16 | | Johnson & Johnson | JNJ | 62.93 | 0.06% | 173.63B | 13.74 | | GlaxoSmithKline plc | GSK | 41.485 | -1.83% | 105.16B | 13.17 | | Sanofi-Aventis | SNY | 37.99 | -1.14% | 99.20B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.49 | 0.20% | 126.03B | 16.61 | | RHHBY.PK | 40.92 | -1.30% | N/A | N/A | | AstraZeneca plc | AZN | 44.7996 | -1.08% | 64.96B | 9.00 | | Abbott Laboratories | ABT | 54.44 | 0.67% | 84.20B | 14.75 | | Bristol-Myers Squibb Co. | BMY | 25.36 | -0.08% | 50.24B | 13.12 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|